about
Shigellosis: Epidemiology in IndiaVirulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutantsVaccination in elite athletes.Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity.Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.The genome of Shigella dysenteriae strain Sd1617 comparison to representative strains in evaluating pathogenesis.Shigella flexneri infection in a newly acquired rhesus macaque (Macaca mulatta)Combination vaccines against diarrheal diseases.Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHBMolecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.Bacterial conjugation in the cytoplasm of mouse cells.Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malariaEvaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.Progress and pitfalls in Shigella vaccine research.The Riemerella anatipestifer AS87_01735 Gene Encodes Nicotinamidase PncA, an Important Virulence FactorUpdate on Campylobacter jejuni vaccine development for preventing human campylobacteriosis.Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study.Inactivated and subunit vaccines to prevent shigellosis.Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine.Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypesRecent progress towards development of a Shigella vaccine.Safety and colonization of two novel VirG(IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta)In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity.Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell-Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae.The Galleria mellonella larvae as an in vivo model for evaluation of Shigella virulence.A Novel Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge
P2860
Q26739692-7BE45AD2-1562-4145-B8B0-C241902BB2BBQ33557800-3FF20B28-E035-4C68-B65D-E6ECCCD4EBE0Q34227424-8990AF56-C47B-4F83-A35C-1BA48BA76EE0Q34394744-7EE47BA1-BBB5-40F5-8AA8-2131533BA068Q35598035-AA38E4BC-70B3-4F95-95A5-637A3B9FB2C3Q35651224-3376479A-F960-4CA7-873A-BE2798C95D7AQ35653427-38B60E48-D55F-42AB-83AC-BFE9C4EEB46DQ35896237-B34DEAED-8AB7-43B5-A50B-7FFAEB181CFBQ35924773-487B8BCE-5736-4528-874E-6F177ABD6010Q36422508-49754A41-67FB-4B42-BEFC-144D15AB71F5Q36949996-F929F4EB-293C-4A81-8AD6-A3C80697171BQ36981626-F3A33A8B-55C2-46A7-BA1F-993112D98DAAQ37032264-A628E337-7190-4DA0-A447-D72DF1D43446Q37105553-E5E70F1B-35FF-46F5-ABA6-B430F8FA3068Q37287109-BA7F4926-A006-425B-AA5C-382A0F054E55Q37461382-F7E93BA9-419B-4405-A7AC-07E6F43484ECQ37477196-C7A32CA0-B395-4D58-B22D-494A2514733BQ37640115-07FD4A4D-BA52-4238-94C9-FE7EB2FF23A8Q37643320-ADF3C85A-66C8-4BC2-8C16-71634C0BCF50Q37720658-EA8FE0D8-FC89-4751-BB91-84A665392E57Q38068954-99ED10EF-E67C-42C0-B612-9703FA72E2F7Q38294092-CC944979-932B-45C3-B98A-D89927DB0280Q38648043-A941685B-60D2-45C5-9249-F5900F40EA0FQ38952300-B033BF12-8D45-41DF-AF63-CB9405384497Q40300987-7DD225CE-18DA-40C0-B24F-B1496792CC90Q57929967-AF238A58-C05E-4A17-ACE2-24C4B9FA2264
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Live-attenuated Shigella vaccines.
@ast
Live-attenuated Shigella vaccines.
@en
type
label
Live-attenuated Shigella vaccines.
@ast
Live-attenuated Shigella vaccines.
@en
prefLabel
Live-attenuated Shigella vaccines.
@ast
Live-attenuated Shigella vaccines.
@en
P2860
P356
P1476
Live-attenuated Shigella vaccines.
@en
P2093
Malabi M Venkatesan
Ryan T Ranallo
P2860
P304
P356
10.1586/14760584.5.5.669
P577
2006-10-01T00:00:00Z